Table 1.
Demographic characteristics and comorbidities among COVID-19 survivors and non-survivors.
| Survivors | Non-survivors | |
|---|---|---|
| (n = 508,766) | (n = 331,435) | |
| North (n = 199,285) | 106,266 (53.3%) | 93,019 (46.7%) |
| Age (years) | ||
| 14–50 (n = 58,747) | 44,201 (75.2%) | 14,546 (24.8%) |
| 51–100 (n = 140,538) | 62,064 (44.2%) | 78,474 (55.8%) |
| Gender | ||
| Women (n = 88,225) | 48,182 (54.6%) | 40,043 (45.4%) |
| Men (n = 111,060) | 58,084 (52.3%) | 52,976 (47.7%) |
| Ethnic group | ||
| White (n = 28,998) | 14,757 (50.9%) | 14,241 (49.1%) |
| Mixed-race (n = 157,676) | 848,85 (53.8%) | 72,791 (46.2%) |
| Black (n = 8,481) | 4,281 (50.5%) | 4,200 (49.5%) |
| Asian (n = 2,821) | 1,642 (58.2%) | 1,179 (41.8%) |
| Indigenous (n = 1,309) | 701 (53.6%) | 608 (46.4%) |
| Comorbidities | ||
| Renal disease (n = 7,276) | 2,405 (33.1%) | 4,871 (66.9%) |
| Liver disease (n = 1,623) | 586 (36.1%) | 1,037 (63.9%) |
| Immunosuppression (n = 4,228) | 1,822 (43.1%) | 2,406 (56.9%) |
| Obesity (n = 11,017) | 5,366 (48.7%) | 5,651 (51.3%) |
| Neurological disease (n = 4890) | 1,761 (36.0%) | 3,129 (64.0%) |
| Pulmonary disease (n = 4,648) | 1,663 (35.8%) | 2,985 (64.2%) |
| Hematologic disease (n = 1,198) | 530 (44.2%) | 668 (55.8%) |
| Diabetes (n = 50,146) | 22,397 (44.7%) | 27,749 (55.3%) |
| Cardiovascular disease (n = 60,834) | 27,351 (45.0%) | 33,483 (55.0%) |
| Central-South (n = 640,916) | 402,500 (62.8%) | 238,416 (37.2%) |
| Age (years) | ||
| 14–50 (n = 183,849) | 152,460 (82.9%) | 31,389 (17.1%) |
| 51–100 (n = 457,067) | 250,040 (55.1%) | 207,027 (44.9%) |
| Gender | ||
| Women (n = 288,383) | 183,063 (63.5%) | 105,320 (36.5%) |
| Men (n = 352,533) | 219,437 (62.2%) | 133,096 (37.8%) |
| Ethnic group | ||
| White (n = 406,146) | 256,977 (63.3%) | 149,169 (36.7%) |
| Mixed-race (n = 188,455) | 118,534 (62.9%) | 69,921 (37.1%) |
| Black (n = 37,682) | 21,438 (56.9%) | 16,244 (43.1%) |
| Asian (n = 7591) | 4,870 (64.2%) | 2,721 (35.8%) |
| Indigenous (n = 1,042) | 681 (65.4%) | 361 (34.6%) |
| Comorbidities | ||
| Renal disease (n = 23,699) | 9,464 (39.9%) | 14,235 (60.1%) |
| Liver disease (n = 5,426) | 2,379 (43.8%) | 3,047 (56.2%) |
| Immunosuppression (n = 15,469) | 7,352 (47.5%) | 8,117 (52.5%) |
| Obesity (n = 53,845) | 30,364 (56.4%) | 23,481 (43.6%) |
| Neurological disease (n = 25,113) | 9,984 (39.8%) | 15,129 (60.2%) |
| Pulmonary disease (n = 25,134) | 10,856 (43.2%) | 14,278 (56.8%) |
| Hematologic disease (n = 4,540) | 2,290 (50.4%) | 2,250 (49.6%) |
| Diabetes (n = 158,467) | 84,854 (53.5%) | 73,613 (46.5%) |
| Cardiovascular disease (n = 225,237) | 121,774 (54.1%) | 103,463 (45.9%) |